Cytokine_NN
rescue_NN
from_IN
glucocorticoid_NN
induced_VBD
apoptosis_NN
in_IN
T_NN
cells_NNS
is_VBZ
mediated_VBN
through_IN
inhibition_NN
of_IN
IkappaBalpha_NN
._.

We_PRP
previously_RB
reported_VBD
that_IN
dexamethasone_NN
-LRB-_-LRB-
DEX_NN
-RRB-_-RRB-
,_,
a_DT
synthetic_JJ
glucocorticoid_NN
,_,
causes_VBZ
apoptosis_NN
in_IN
mature_JJ
Th_NN
cell_NN
lines_NNS
,_,
and_CC
that_IN
this_DT
induction_NN
of_IN
cell_NN
death_NN
is_VBZ
prevented_VBN
by_IN
specific_JJ
cytokines_NNS
,_,
namely_RB
,_,
by_IN
IL-2_NN
in_IN
Th1_NN
cells_NNS
and_CC
by_IN
IL-4_NN
in_IN
Th2_NN
cells_NNS
._.

We_PRP
now_RB
show_VBP
that_IN
this_DT
differential_JJ
rescue_NN
by_IN
specific_JJ
cytokines_NNS
in_IN
Th_NN
cells_NNS
correlates_VBZ
with_IN
the_DT
level_NN
of_IN
IkappaBalpha_NN
that_WDT
is_VBZ
regulated_VBN
by_IN
DEX_NN
and_CC
cytokines_NNS
._.

In_IN
both_DT
cell_NN
types_NNS
the_DT
cellular_JJ
levels_NNS
of_IN
IkappaBalpha_NN
mRNA_NN
and_CC
protein_NN
were_VBD
evaluated_VBN
by_IN
DEX_NN
treatment_NN
._.

Interestingly_RB
,_,
the_DT
DEX-mediated_JJ
IkappaBalpha_NN
induction_NN
was_VBD
completely_RB
inhibited_VBN
by_IN
IL-2_NN
,_,
but_CC
not_RB
IL-4_NN
,_,
in_IN
Th1_NN
cells_NNS
,_,
while_IN
the_DT
reverse_JJ
profile_NN
was_VBD
seen_VBN
in_IN
Th2_NN
cells_NNS
._.

In_IN
both_DT
cell_NN
types_NNS
,_,
the_DT
cytokine_NN
that_WDT
inhibits_VBZ
the_DT
induction_NN
of_IN
IkappaBalpha_NN
by_IN
DEX_NN
,_,
also_RB
rescues_VBZ
these_DT
cells_NNS
from_IN
DEX-induced_JJ
apoptosis_NN
,_,
although_IN
the_DT
rescue_NN
cytokine_NN
is_VBZ
different_JJ
in_IN
Th1_NN
and_CC
Th2_NN
cells_NNS
._.

Our_PRP$
results_NNS
imply_VBP
that_IN
T_NN
cells_NNS
need_VBP
to_TO
maintain_VB
a_DT
certain_JJ
level_NN
of_IN
NF-kappaB_NN
transcriptional_JJ
activity_NN
in_IN
order_NN
to_TO
survive_VB
;_:
up_RB
-_CD
or_CC
down-regulation_NN
of_IN
nuclear_JJ
NF_NN
kappaB_NN
through_IN
modulation_NN
of_IN
IkappaBalpha_NN
expression_NN
by_IN
cytokines_NNS
or_CC
DEX_NN
may_MD
lead_VB
to_TO
cell_NN
survival_NN
or_CC
cell_NN
death_NN
,_,
respectively_RB
._.

